Registration - Consultant

Boehringer Ingelheim (Canada) Ltd. / Boehringer Ingelheim (Canada) Ltd. / Emily-Jean Gallant, Consultant

Registration Information

Client name: Boehringer Ingelheim (Canada) Ltd. / Boehringer Ingelheim (Canada) Ltd.
Lobbyist name: Emily-Jean Gallant, Consultant
Initial registration start date: 2023-05-18
Registration status: Active
Registration Number: 954842-374728

Associated Communications

Total Number of Communication Reports: 3

Monthly communication reports in the last 6 months: 3

Version 4 of 4 (2025-10-14 to present)

Registration versions:

Version 4 of 4 (2025-10-14 to present)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Aboriginal Affairs, Health, Science and Technology	Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.	Policies or Program
Aboriginal Affairs, Health, Science and Technology	Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).	Policies or Program

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Agriculture and Agri-Food Canada (AAFC)
Finance Canada (FIN)
Health Canada (HC)
House of Commons
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
5180 S Service Rd
Burlington, ON L7L 5H4
Canada

Telephone number: 905-639-0333

Client representative

Mehmood Alibhai, Director, National Policy and Market Access

Parent Company Information

Boehringer Ingelheim (Canada) Ltd. / Boehringer Ingelheim (Canada) Ltd. is not a subsidiary of any other parent companies.

Coalition Members Information

Boehringer Ingelheim (Canada) Ltd. / Boehringer Ingelheim (Canada) Ltd. is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Boehringer Ingelheim (Canada) Ltd. / Boehringer Ingelheim (Canada) Ltd. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Boehringer Ingelheim (Canada) Ltd. / Boehringer Ingelheim (Canada) Ltd. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Emily-Jean Gallant | No public offices held

Business address:
2100 Thurston Drive
Unit 13A
Ottawa, ON K1G 4K8
Canada

Telephone number: 613-265-0643

Consultant Firm and Address

Firm: Wellington Dupont Public Affairs

Address:
2100 Thurston Drive
Unit 13A
Ottawa, ON K1G 4K8
Canada

Telephone number: 613-265-0643

Boehringer Ingelheim (Canada) Ltd./Boehringer Ingelheim (Canada) Ltd.

The following names have been used on or after July 2, 2008

Name	From	To
Boehringer Ingelheim (Canada) Ltd./Boehringer Ingelheim (Canada) Ltd.	2023-05-18	current

Boehringer Ingelheim (Canada) Ltd. / Boehringer Ingelheim (Canada) Ltd.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Date Modified:: 2025-08-29

Search and menus

Language selection

Registration - Consultant

Boehringer Ingelheim (Canada) Ltd. / Boehringer Ingelheim (Canada) Ltd. / Emily-Jean Gallant, Consultant

Registration Information

Associated Communications

Version 4 of 4 (2025-10-14 to present)

Version 4 of 4 (2025-10-14 to present)

Subject Matter Details

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address